After recruitment to the TME, TAMs release different factors—such as VEGF, IL-6, Angiopoietin 2 (ANG2), and insulin-like growth factor-binding protein 1 (IGFBP1)—to stimulate neovascularization in the tumor [86,87,88,89]. This evidence concerns the gene VEGFA and neoplasm.